Canngea Secures Supply Agreement with ECS Botanics

We are pleased to have secured a one year, rolling supply agreement with Australian cannabis company, ESC Botanics.

Under the agreement and via ECS’ existing Murray Meds licence, they will supply Canngea with a minimum of $410,000 in GMP manufactured medicinal cannabis products per year, including dry flower and oils. 

This agreement is key to enhancing local supply capabilities for our clients in Australia and internationally, and is a significant increase in Canngea’s local supply capability.

Collaborations like this strengthen the ability of the Australian medicinal cannabis industry to service the growing demand for safe, high-quality, and affordable products. 

We were drawn to this opportunity particularly because ECS shares our values and vision around sustainability throughout the supply chain, which is something we’re passionate about.

ECS Managing Director, Alex Keach, agreed the deal is further validation of the growing market in Australia.